课题基金 / 基金详情

项目摘要

项目成果

Martin L. Privalsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We (and others) have identified a series of corepressor and coactivator proteins that physically associate with nuclear receptors, recruit additional proteins, and help mediate transcriptional repression or activation. Many signals that impact on nuclear receptor function manifest their effects through changes in corepressor and coactivator recruitment or function. We propose to continue our research into how the actions of nuclear receptors are mediated through these coregulators. We will address specific aspects of 5 broad questions: Specific Aim 1. How can otherwise closely-related isoforms of the same nuclear receptor display very different transcriptional properties: elucidation of the divergent transcriptional properties of thyroid hormone receptors beta 1 and beta 2. Specific aim 2. How do newly recognized N-terminal receptor interaction domains (nRID) in SMRT and N- CoR contribute to the actions of these corepressors? Specific Aim 3. How are the composition and transcriptional regulatory properties of the corepressor complex regulated by phosphorylation? Specific Aim 4. How does alternative mRNA splicing of SMRT and N-CoR customize their molecular properties? Specific Aim 5. How does alternative mRNA splicing of SMRT and N-CoR contribute to their biological functions? These experiments seek both to enhance our understanding of how nuclear receptors operate in mediating normal physiology, and to improve our knowledge of how aberrations in coregulator function lead to disease. Relevance: The proposed studies will improve our knowledge of how important hormones function in healthy individuals. They also will reveal how disruptions to these functions can lead to disease, and may provide clues resulting in improved treatments.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.
p160 共激活因子 PAS-B 基序可稳定核受体结合,并有助于甲状腺激素受体的亚型特异性调节。
DOI: 10.1074/jbc.m109.007542
发表时间: 2009
期刊: The Journal of biological chemistry
影响因子: --
作者: [Privalsky,MartinL, Lee,Sangho, Hahm,JohnnieB, Young,BrianaM, Fong,RebeccaNG, Chan,IvanH]
通讯作者: Chan,IvanH
Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
垂体对甲状腺激素综合征的抵抗与选择性损害 β2 亚型功能的 T3 受体突变体有关。
DOI: 10.1210/me.2005-0014
发表时间: 2005
期刊: Molecular endocrinology (Baltimore, Md.)
影响因子: --
作者: [Wan,Wei, Farboud,Behnom, Privalsky,MartinL]
通讯作者: Privalsky,MartinL
An improved high throughput protein-protein interaction assay for nuclear hormone receptors.
一种改进的核激素受体高通量蛋白质-蛋白质相互作用测定。
DOI: 10.1621/nrs.05002
发表时间: 2007
期刊: Nuclear receptor signaling
影响因子: --
作者: [Goodson,MichaelL, Farboud,Behnom, Privalsky,MartinL]
通讯作者: Privalsky,MartinL
The two major isoforms of thyroid hormone receptor, TRα1 and TRβ1, preferentially partner with distinct panels of auxiliary proteins.
甲状腺激素受体的两种主要亚型 TRα1 和 TRβ1 优先与不同的辅助蛋白组结合。
DOI: 10.1016/j.mce.2013.11.015
发表时间: 2014
期刊: Molecular and cellular endocrinology
影响因子: 4.1
作者: [Hahm,JohnnieB, Schroeder,AmyC, Privalsky,MartinL]
通讯作者: Privalsky,MartinL
11
    Role of cofactors in nuclear hormone receptor function.
    • 批准号:
      8010061
    • 项目类别:
    • 资助金额:
      $3.4万
    • 财政年份:
      2010
    • 负责人:
      Martin L. Privalsky
    • 依托单位:
    Role of thyroid hormone receptor mutants in hepatocellular carcinoma
    • 批准号:
      7175777
    • 项目类别:
    • 资助金额:
      $14.78万
    • 财政年份:
      2006
    • 负责人:
      Martin L. Privalsky
    • 依托单位:
    Role of thyroid hormone receptor mutants in hepatocellular carcinoma
    • 批准号:
      7392190
    • 项目类别:
    • 资助金额:
      $17.85万
    • 财政年份:
      2006
    • 负责人:
      Martin L. Privalsky
    • 依托单位:
    COFACTORS AND NUCLEAR HORMONE RECEPTOR FUNCTION
    • 批准号:
      6342516
    • 项目类别:
    • 资助金额:
      $16.31万
    • 财政年份:
      1998
    • 负责人:
      Martin L. Privalsky
    • 依托单位:
    国内基金
    海外基金
    帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
    • 批准号:
      32170319
    • 项目类别:
      面上项目
    • 资助金额:
      58.00万元
    • 批准年份:
      2021
    • 负责人:
      董春海
    • 依托单位:
    帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      董春海
    • 依托单位:
    ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
    番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
    • 批准号:
      31372080
    • 项目类别:
      面上项目
    • 资助金额:
      80.0万元
    • 批准年份:
      2013
    • 负责人:
      杨迎伍
    • 依托单位: